Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-term Study of APTA-2217 in Patients With Chronic Obstructive Pulmonary Disease

NCT00246935 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00246935
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00246935 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-term Study of APTA-2217 in Patients With Chronic Obstructive Pulmonary Disease
Lead sponsor
AstraZeneca
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2005
Completion date
October 31, 2007
Enrollment
150
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease (copd)